The advantages of switch to subcutaneous bortezomib in the real life

Silvia Mangiacavalli, Federica Cocito, Virginia Valeria Ferretti, Maya Ganzetti, Claudio Salvatore Cartia, Alessandro Corso

Research output: Contribution to journal › Article

Original languageEnglish
Pages (from-to)1505-1507
Number of pages3
JournalLeukemia and Lymphoma
Volume59
Issue number6
DOIs
Publication statusPublished - Jun 2018

Keywords

  • Administration, Intravenous
  • Antineoplastic Agents/administration & dosage
  • Bortezomib/administration & dosage
  • Humans
  • Injections, Subcutaneous
  • Multiple Myeloma/diagnosis
  • Patient Compliance
  • Patient Satisfaction
  • Treatment Outcome

Cite this

The advantages of switch to subcutaneous bortezomib in the real life. / Mangiacavalli, Silvia; Cocito, Federica; Ferretti, Virginia Valeria; Ganzetti, Maya; Cartia, Claudio Salvatore; Corso, Alessandro.

In: Leukemia and Lymphoma, Vol. 59, No. 6, 06.2018, p. 1505-1507.

Research output: Contribution to journal › Article

Mangiacavalli, S, Cocito, F, Ferretti, VV, Ganzetti, M, Cartia, CS & Corso, A 2018, 'The advantages of switch to subcutaneous bortezomib in the real life', Leukemia and Lymphoma, vol. 59, no. 6, pp. 1505-1507. https://doi.org/10.1080/10428194.2017.1382695
Mangiacavalli S, Cocito F, Ferretti VV, Ganzetti M, Cartia CS, Corso A. The advantages of switch to subcutaneous bortezomib in the real life. Leukemia and Lymphoma. 2018 Jun;59(6):1505-1507. https://doi.org/10.1080/10428194.2017.1382695
Mangiacavalli, Silvia ; Cocito, Federica ; Ferretti, Virginia Valeria ; Ganzetti, Maya ; Cartia, Claudio Salvatore ; Corso, Alessandro. / The advantages of switch to subcutaneous bortezomib in the real life. In: Leukemia and Lymphoma. 2018 ; Vol. 59, No. 6. pp. 1505-1507.
@article{2d6bf4554dca401a9fb4741f4e55126c,
title = "The advantages of switch to subcutaneous bortezomib in the real life",
keywords = "Administration, Intravenous, Antineoplastic Agents/administration & dosage, Bortezomib/administration & dosage, Humans, Injections, Subcutaneous, Multiple Myeloma/diagnosis, Patient Compliance, Patient Satisfaction, Treatment Outcome",
author = "Silvia Mangiacavalli and Federica Cocito and Ferretti, {Virginia Valeria} and Maya Ganzetti and Cartia, {Claudio Salvatore} and Alessandro Corso",
year = "2018",
month = "6",
doi = "10.1080/10428194.2017.1382695",
language = "English",
volume = "59",
pages = "1505--1507",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - The advantages of switch to subcutaneous bortezomib in the real life

AU - Mangiacavalli, Silvia

AU - Cocito, Federica

AU - Ferretti, Virginia Valeria

AU - Ganzetti, Maya

AU - Cartia, Claudio Salvatore

AU - Corso, Alessandro

PY - 2018/6

Y1 - 2018/6

KW - Administration, Intravenous

KW - Antineoplastic Agents/administration & dosage

KW - Bortezomib/administration & dosage

KW - Humans

KW - Injections, Subcutaneous

KW - Multiple Myeloma/diagnosis

KW - Patient Compliance

KW - Patient Satisfaction

KW - Treatment Outcome

U2 - 10.1080/10428194.2017.1382695

DO - 10.1080/10428194.2017.1382695

M3 - Article

C2 - 28980500

VL - 59

SP - 1505

EP - 1507

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 6

ER -

Access to Document

Related content

Projects

SAN MATTEO - TRAPIANTO DI CELLULE STAMINALI E MALATTIE CURABILI CON TRAPIANTO

Project: Other project